Published in J Am Coll Cardiol on January 04, 2007
Drug-induced long QT syndrome. Pharmacol Rev (2010) 2.55
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation (2010) 2.49
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2010) 2.41
Prolonged Tpeak-to-tend interval on the resting ECG is associated with increased risk of sudden cardiac death. Circ Arrhythm Electrophysiol (2011) 2.35
Is there a significant transmural gradient in repolarization time in the intact heart? Cellular basis of the T wave: a century of controversy. Circ Arrhythm Electrophysiol (2009) 2.16
Clinical and genetic determinants of torsade de pointes risk. Circulation (2012) 1.67
Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program. Cardiovasc Drugs Ther (2015) 1.41
Potential pro-arrhythmic effect of cardiac resynchronization therapy. J Saudi Heart Assoc (2013) 1.26
Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm (2007) 1.23
The impact of varying autonomic states on the dynamic beat-to-beat QT-RR and QT-TQ interval relationships. Br J Pharmacol (2008) 1.00
Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review. ScientificWorldJournal (2012) 0.98
Drug-induced spatial dispersion of repolarization. Cardiol J (2008) 0.94
Bradycardia alters Ca(2+) dynamics enhancing dispersion of repolarization and arrhythmia risk. Am J Physiol Heart Circ Physiol (2013) 0.91
The Contribution of HCN4 to normal sinus node function in humans and animal models. Pacing Clin Electrophysiol (2009) 0.90
Torsades de pointes during complete atrioventricular block: Genetic factors and electrocardiogram correlates. Can J Cardiol (2010) 0.88
Evaluation of repolarization dynamics using the QT-RR regression line slope and intercept relationship during 24-h Holter ECG. Heart Vessels (2014) 0.87
Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart. Br J Pharmacol (2009) 0.85
Controlled exposure study of air pollution and T-wave alternans in volunteers without cardiovascular disease. Environ Health Perspect (2012) 0.82
Proarrhythmic and Torsadogenic Effects of Potassium Channel Blockers in Patients. Card Electrophysiol Clin (2016) 0.82
Surface Electrocardiogram Predictors of Sudden Cardiac Arrest. Ochsner J (2016) 0.82
T-peak to T-end abnormality in pediatric patients with syncope. Iran J Pediatr (2012) 0.79
Static and Dynamic Electrocardiographic Patterns Preceding Torsades de Pointes in the Acquired and Congenital Long QT Syndrome. Comput Cardiol (2010) (2010) 0.78
Remote noninvasive allograft rejection monitoring for heart transplant recipients: study protocol for the novel evaluation with home electrocardiogram and remote transmission (NEW HEART) study. BMC Cardiovasc Disord (2012) 0.78
Congenital complete atrioventricular block associated with QT prolongation: Description of a patient with an unusual outcome. Pediatr Cardiol (2010) 0.78
Advanced Age, Female Gender and Delay in Pacemaker Implantation May Cause TdP in Patients With Complete Atrioventricular Block. Indian Pacing Electrophysiol J (2010) 0.77
Impact of obstructive and central apneas on ventricular repolarisation: lessons learned from studies in man and pigs. Clin Res Cardiol (2016) 0.77
Prolonged Tp-e Interval, Tp-e/QT Ratio and Tp-e/QTc Ratio in Patients with Type 2 Diabetes Mellitus. Endocrinol Metab (Seoul) (2016) 0.76
Repolarization Heterogeneity: Beyond the QT Interval. J Am Heart Assoc (2016) 0.76
Efficiency of quantification of cardiac electrical heterogeneity: via QT dispersion, transmural dispersion, or both. Biol Sport (2015) 0.75
Hypokalemia in women and methadone therapy are the strongest non-cardiologic factors associated with QT prolongation in an emergency department setting. J Electrocardiol (2017) 0.75
Assessment of ventricular repolarization inhomogeneity in patients with mitral valve prolapse: value of T wave peak to end interval. Int J Clin Exp Med (2014) 0.75
Prognostic value of Tpeak-Tend interval in patients with acute pulmonary embolism. BMC Cardiovasc Disord (2015) 0.75
Evaluation of Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio in patients with subclinical hypothyroidism. Ther Adv Endocrinol Metab (2017) 0.75
Torsade de Pointes Triggered by Early Ventricular Escape Beats in a Patient with Complete Atrioventricular Block. Case Rep Cardiol (2016) 0.75
The evolution of electrocardiographic changes in patients with Duchenne muscular dystrophies. Korean J Pediatr (2017) 0.75
Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases. Pediatr Cardiol (2017) 0.75
Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol (2011) 3.86
Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med (2014) 3.80
J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol (2008) 2.87
Preventing sudden death of athletes with electrocardiographic screening: what is the absolute benefit and how much will it cost? J Am Coll Cardiol (2012) 2.84
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm (2010) 2.79
The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol (2010) 2.56
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation (2011) 2.56
Fever-induced Brugada pattern: how common is it and what does it mean? Heart Rhythm (2013) 2.25
Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation (2011) 2.23
Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation (2004) 2.14
Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. J Am Coll Cardiol (2012) 2.13
Inaccessibility to quinidine therapy is about to get worse. J Am Coll Cardiol (2013) 2.12
What do we know about the "malignant form" of early repolarization? J Am Coll Cardiol (2013) 2.11
Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation (2006) 2.11
To the editor--Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine. Heart Rhythm (2010) 2.10
The top 10 reasons to avoid defibrillation threshold testing during ICD implantation. Heart Rhythm (2008) 2.07
Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace (2013) 1.97
Distinguishing "benign" from "malignant early repolarization": the value of the ST-segment morphology. Heart Rhythm (2011) 1.90
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89
Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls. Heart Rhythm (2004) 1.86
Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) (2003) 1.78
The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization. J Mol Cell Cardiol (2010) 1.78
Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol (2008) 1.64
Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol (2007) 1.63
Left atrial contractile function following a successful modified Maze procedure at surgery and the risk for subsequent thromboembolic stroke. J Am Coll Cardiol (2011) 1.62
Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome. Eur Heart J (2005) 1.61
Idiopathic left ventricular tachycardia with a right bundle branch block morphology and left axis deviation ("Belhassen type"): results of radiofrequency ablation in 18 patients. Isr Med Assoc J (2004) 1.61
A novel mutation in the HCN4 gene causes symptomatic sinus bradycardia in Moroccan Jews. J Cardiovasc Electrophysiol (2010) 1.60
Pacemakers and magnetic resonance imaging: no longer an absolute contraindication when scanned correctly. Isr Med Assoc J (2010) 1.59
Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome. Pacing Clin Electrophysiol (2009) 1.59
Diagnostic yield of extensive infectious panel testing in acute pericarditis. Cardiology (2011) 1.55
Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia. Circulation (2007) 1.55
Effect of bundle branch block patterns on mortality in hospitalized patients with heart failure. Am J Cardiol (2008) 1.53
Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol (2007) 1.50
Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia. J Cardiovasc Electrophysiol (2004) 1.48
Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator. Heart Rhythm (2010) 1.47
Cardiovascular risk factors in men with ischemic heart disease and erectile dysfunction. Urology (2013) 1.47
Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant. Heart Rhythm (2012) 1.46
Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene. Heart Rhythm (2011) 1.46
Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System. Am J Cardiol (2011) 1.45
The site of origin of torsade de pointes. Heart (2011) 1.45
The "short-coupled" variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia? J Cardiovasc Electrophysiol (2005) 1.44
Radiofrequency ablation of atrioventricular nodal reentry tachycardia: a 14 year experience with 901 patients at the Tel Aviv Sourasky Medical Center. Isr Med Assoc J (2006) 1.42
Electrophysiological testing and ablation in an asymptomatic child with Wolff-Parkinson-White syndrome. Isr Med Assoc J (2010) 1.41
Functional response to cardiac resynchronization therapy in patients with renal dysfunction and subsequent long-term mortality. J Cardiovasc Electrophysiol (2014) 1.41
Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias. J Cardiovasc Electrophysiol (2008) 1.40
Risk of sudden death among young individuals with J waves and early repolarization: putting the evidence into perspective. Heart Rhythm (2011) 1.40
Arrhythmogenic right ventricular cardiomyopathy: an unusual possible cause of arrhythmia in a 78 year old man with a 40 year history of palpitations. Isr Med Assoc J (2014) 1.39
Symptomatic venous thromboembolism in elderly patients following major orthopedic surgery of the lower limb is associated with elevated vitamin B12 serum levels. Clin Biochem (2012) 1.39
The prevalence of reversible cardiovascular risk factors in Israelis aged 25-55 years. Isr Med Assoc J (2006) 1.38
Tilt training: does it have a role in preventing vasovagal syncope? Pacing Clin Electrophysiol (2007) 1.38
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug. J Am Coll Cardiol (2004) 1.28
EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace (2010) 1.25
Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm (2007) 1.23
Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing Clin Electrophysiol (2005) 1.23
Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis (2003) 1.22
Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol (2006) 1.20
Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm (2007) 1.20
H1N1 influenza: initial chest radiographic findings in helping predict patient outcome. Radiology (2010) 1.20
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace (2015) 1.13
Short-term exposure to air pollution and inflammation-sensitive biomarkers. Environ Res (2007) 1.11
Platelet counts and platelet activation markers in obese subjects. Mediators Inflamm (2008) 1.10
The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option? Pacing Clin Electrophysiol (2002) 1.08
Inhibition of biventricular pacemakers by oversensing of far-field atrial depolarization. Pacing Clin Electrophysiol (2002) 1.07
Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry. Heart Rhythm (2008) 1.07
Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm (2012) 1.06
Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation: results from a worldwide survey in 34 943 atrial fibrillation ablation procedures. Circ Arrhythm Electrophysiol (2014) 1.05
Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes? J Electrocardiol (2009) 1.04
Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction. Heart Rhythm (2007) 1.04
Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. J Am Coll Cardiol (2011) 1.03
Incidence of cytomegalovirus-associated thrombosis and its risk factors: a case-control study. Thromb Res (2010) 1.03
Guidelines for treating cardiac manifestations of organophosphates poisoning with special emphasis on long QT and Torsades De Pointes. Crit Rev Toxicol (2007) 1.02
Environmental air pollution has decremental effects on pulmonary function test parameters up to one week after exposure. Am J Med Sci (2009) 1.01
Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU). Isr Med Assoc J (2008) 0.97